Full Press Release Details
Aeterna Zentaris Learns of Class Action Lawsuits Filed and Denies Allegations
Qu bec City, Canada, June 19, 2012 Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the Company ) today
announces that the Company has learned that two putative class action lawsuits have been filed against it alleging failures to disclose certain information under U.S. federal securities laws. The Company is in the process of reviewing the
allegations, believes they are without merit and stands behind its continuous public disclosure record. Aeterna Zentaris believes that there is absolutely no basis for the lawsuits, and the Company intends to defend itself vigorously.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The
Company s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit www.aezsinc.com.
Ginette Beaudet Valli res
Investor Relations Coordinator
Director of Communications
(418) 652-8525 ext. 406